Title:
APPLICATION OF ERH GENE IN PREPARATION OF PRODUCT FOR DIAGNOSIS AND TREATMENT OF BLADDER CANCER
Document Type and Number:
WIPO Patent Application WO/2018/145371
Kind Code:
A1
Abstract:
Provided in the present invention are an application of the ERH gene in the preparation of a product for the diagnosis and treatment of bladder cancer.
Inventors:
HAN CONGHUI (CN)
LV QIAN (CN)
PANG KUN (CN)
HAO LIN (CN)
LIU YING (CN)
LV QIAN (CN)
PANG KUN (CN)
HAO LIN (CN)
LIU YING (CN)
Application Number:
PCT/CN2017/085951
Publication Date:
August 16, 2018
Filing Date:
May 25, 2017
Export Citation:
Assignee:
XUZHOU CENTRAL HOSPITAL (CN)
International Classes:
C12Q1/68; A61K31/713; A61K39/395; A61K45/00; A61P35/00; C12N15/113; C12N15/67; G01N33/574; G01N33/577; G01N33/68
Domestic Patent References:
| WO2014118334A1 | 2014-08-07 | |||
| WO2013074837A1 | 2013-05-23 |
Foreign References:
| CN105586422A | 2016-05-18 | |||
| CN104450893A | 2015-03-25 |
Other References:
MENG-TZU WENG, ET AL.: "Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 109, no. 52, 10 December 2012 (2012-12-10), pages E3659 - E3667, XP055532373
Attorney, Agent or Firm:
GENUINEWAYS INTELLECTUAL PROPERTY AGENCY (CN)
Download PDF: